Priming with Toll-like receptor 3 agonist or interferon-gamma enhances the therapeutic effects of human mesenchymal stem cells in a murine model of atopic dermatitis

BACKGROUND: Atopic dermatitis (AD) is a chronic and relapsing inflammatory skin disease. Great efforts have been recently made to treat AD using mesenchymal stem cells (MSCs), which have immunomodulatory functions. However, the immunomodulatory effects of MSCs need to be enhanced for clinical applic...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Stem Cell Res Ther
Main Authors: Park, Arum, Park, Hyojung, Yoon, Jisun, Kang, Dayeon, Kang, Myoung-Hee, Park, Y-Y, Suh, Nayoung, Yu, Jinho
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2019
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6387524/
https://ncbi.nlm.nih.gov/pubmed/30795812
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13287-019-1164-6
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados